RxDoctor Payments Data

David Ranney

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Grand Rapids, MINPI 1033451497

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $10,000 of the $14,226 with a category attached, or 70.3%. Medtronic accounts for 87.9% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2024 at $8,813 and has fallen 99.8% since, to $20 in 2025.

$14,226in general payments, 2019–2025

Across 57 payments — averaging $249.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$13K
  • Atricure, Inc.$1K
  • Edwards Lifesciences$598
  • Baxter Healthcare$92

What the payments were for

  • Speaking & faculty fees$10,00070%
  • Travel & lodging$1,66912%
  • Food & beverage$2,55818%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic44$12,508
Atricure, Inc.7$1,028
Edwards Lifesciences5$598
Baxter Healthcare1$92

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,226 in reported general payments places this provider in the 70th percentile of 182 thoracic surgery (cardiothoracic vascular surgery) providers in Michigan.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Michigan

Medicare billing

Part B allowed, 2024
$76,961
Medicare patients
117
Services billed
204

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban11$5,212
Metoprolol Succinate21$296

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Grand Rapids

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →